How to Track and Analyze Intuitive Surgical Procedure Growth in 2024: A 5-Step Checklist

Who This Checklist Is For

This checklist is for anyone responsible for reporting, forecasting, or justifying robotic surgery program performance: surgical program directors, OR managers, finance analysts, and hospital administrators dealing with Intuitive Surgical systems (da Vinci, Ion).

If you've ever submitted a quarterly report only to have your CFO question the numbers, or if you've tried to forecast next year's case volume based on messy data, this 5-step process is for you. It's built from mistakes I've made (and documented) over the past 3 years.

Step 1: Establish Your Data Baseline – System by System

Most teams make a critical error here: they look at total procedure numbers without isolating by platform. An Ion case and a da Vinci 5 case are fundamentally different in revenue, OR time, and resource allocation.

The checklist item: Create a separate log for each system in your fleet. For each platform (da Vinci X, Xi, 5, Ion, SP), record:

• Monthly procedure count
• Average OR time per case type (this changes over time)
• Instrument utilization per case

I once submitted a glowing report showing 15% growth in Q1 2023. The good growth. Turned out it was 50% from the Ion platform (pulmonology cases) and only 3% from da Vinci. The Ion cases were much shorter and lower revenue. My "15% growth" was almost flat in terms of overall program revenue. That mistake cost me a week of rework and a very uncomfortable meeting with the VP of Surgical Services.

(Note to self: always, always segment by platform before reporting.)

Step 2: Define 'Procedure Growth' – and Stick to It

This sounds basic, but I've seen three different definitions used in the same quarterly review. You need to agree on a single metric. Here are the options:

• Year-over-Year (YoY): Compare current month/quarter to same period last year. This is the most stable metric (and what Intuitive uses in their earnings calls).
• Sequential (QoQ): Current quarter vs. previous quarter. Captures short-term trends but vulnerable to seasonality (Q4 is always heavy, Q1 is light).
• Rolling 12 months: A moving average. Great for smoothing out anomalies, but it's lagging – you won't spot a decline until it's 12 months old.

My recommendation (learned the hard way): Use YoY as your primary, with rolling 12 months as a sanity check. Why? In Q2 2024, we had a huge spike from a new urology group starting. QoQ looked like 22% growth. But YoY? Only 4% – the new group was replacing volume from a retiring surgeon, not adding net new cases. The YoY metric saved us from an overinvestment in additional da Vinci 5 consoles.

Step 3: Filter Out the Noise – Adjust for Surgeon Onboarding

Here's the one that trips up most people. New surgeon onboarding creates a temporary bump that looks like sustainable growth but isn't.

The checklist item: Flag any procedure growth that correlates with a surgeon who has been in practice for fewer than 6 months. Their initial case ramp (typically 15–25 cases in months 1–3) is a one-time event, not growth.

In September 2022, I was patting myself on the back for a 12% procedure increase. I had even put it in the board presentation. Then my colleague asked: "How much of that is Dr. Lee?" Checked the data: 70% of the growth was from one surgeon who had started in July. Take her out, the program was actually down 2%. Totally embarrassing. I now always include an "excl. new surgeons" column in every report.

Honestly, you should also track surgeon-specific volume by procedure type. Some surgeons may be increasing their case volume, while others are decreasing. The net number can hide both trends.

Step 4: Validate with System Utilization Data (Don't Trust the Log Alone)

This step is critical and often overlooked. The procedure log from your staff may not match the system's internal data. Intuitive systems record every startup, every case, every console hour. Compare your log against the system's data periodically.

In Q4 last year, I found a 9% discrepancy between our log and the da Vinci 5's internal record. We had missed an entire weekend's worth of cases – 14 procedures – because the scheduler forgot to log them after a staff change. That error would have made our growth look lower than it actually was, and would have affected our procurement forecast for the next year. (We caught it thanks to a tip from a scrub tech who said, "That weekend seemed busy.")

The checklist item: Quarterly audit: pull the system utilization report from Intuitive's customer portal or your local rep, and cross-check against your manual log. If the discrepancy is more than 5%, investigate.

Step 5: Forecast Using the 'Procedure per Console' Metric

Forget complex models. The single best predictor of future growth potential is your average procedure count per console per month.

• Benchmark (based on data from 2023–2024, your actual numbers may vary): A high-performing console averages 35–45 procedures per month (for da Vinci). Under 20 per month suggests underutilization or scheduling bottlenecks.
• If your current console is running at 40/month and you're adding surgeons, you'll hit a ceiling. That's when you need to talk about a second console or schedule optimization.
• If you're below 20/month, adding a console is the wrong answer – you need to address utilization first.

But here's the trap: Don't use total fleet procedures / total fleet consoles. You need per console numbers. Mixing a da Vinci 5 in thoracic (high volume) with an Ion in pulmonology (lower volume) will give you a misleading average. (Surprise, surprise – I made this mistake in 2023 and had to redo the entire capacity plan.)

Common Mistakes (and How to Catch Them)

Here are the three errors I see most often, and that I've personally made:

1. Ignoring case mix changes. If your system is doing more partial nephrectomies and fewer prostatectomies, the procedure count may go down but the revenue per case goes up. Growth isn't just a number – it's about value.
2. Using total OR minutes as a proxy for growth. OR time varies by surgeon and procedure. A slow surgeon dragging out a cholecystectomy doesn't mean you have a growing program. Use procedure count as the primary metric, not time.
3. Forgetting to account for capital equipment downtime. If a system was down for a software upgrade for a week, that week's missing procedures aren't lost growth – they're a temporary blip. But if you don't adjust for it, your monthly average will be artificially low.

Bottom line: Procedure growth analysis is like onion layers – the more you peel, the more there is to learn. But with this checklist, you can avoid the most common pitfalls and present data that actually tells the story of your program.

Prices and benchmarks as of 2025. Verify current data with your Intuitive Surgical representative and hospital finance team. Regulatory information is for general guidance only – consult official sources for current requirements.